2-174812294-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001822.7(CHN1):​c.886+15G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.463 in 1,596,542 control chromosomes in the GnomAD database, including 178,494 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 12129 hom., cov: 32)
Exomes 𝑓: 0.47 ( 166365 hom. )

Consequence

CHN1
NM_001822.7 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0350

Publications

7 publications found
Variant links:
Genes affected
CHN1 (HGNC:1943): (chimerin 1) This gene encodes GTPase-activating protein for ras-related p21-rac and a phorbol ester receptor. It is predominantly expressed in neurons, and plays an important role in neuronal signal-transduction mechanisms. Mutations in this gene are associated with Duane's retraction syndrome 2 (DURS2). Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CHN1 Gene-Disease associations (from GenCC):
  • Duane retraction syndrome 2
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • Duane retraction syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 2-174812294-C-T is Benign according to our data. Variant chr2-174812294-C-T is described in ClinVar as Benign. ClinVar VariationId is 332464.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.487 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHN1NM_001822.7 linkc.886+15G>A intron_variant Intron 9 of 12 ENST00000409900.9 NP_001813.1 P15882-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHN1ENST00000409900.9 linkc.886+15G>A intron_variant Intron 9 of 12 1 NM_001822.7 ENSP00000386741.4 P15882-1

Frequencies

GnomAD3 genomes
AF:
0.364
AC:
55351
AN:
151954
Hom.:
12137
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.110
Gnomad AMI
AF:
0.566
Gnomad AMR
AF:
0.317
Gnomad ASJ
AF:
0.416
Gnomad EAS
AF:
0.450
Gnomad SAS
AF:
0.496
Gnomad FIN
AF:
0.472
Gnomad MID
AF:
0.430
Gnomad NFE
AF:
0.491
Gnomad OTH
AF:
0.382
GnomAD2 exomes
AF:
0.426
AC:
103784
AN:
243890
AF XY:
0.440
show subpopulations
Gnomad AFR exome
AF:
0.0981
Gnomad AMR exome
AF:
0.246
Gnomad ASJ exome
AF:
0.401
Gnomad EAS exome
AF:
0.459
Gnomad FIN exome
AF:
0.470
Gnomad NFE exome
AF:
0.494
Gnomad OTH exome
AF:
0.441
GnomAD4 exome
AF:
0.473
AC:
683267
AN:
1444470
Hom.:
166365
Cov.:
33
AF XY:
0.476
AC XY:
340547
AN XY:
716138
show subpopulations
African (AFR)
AF:
0.0936
AC:
3109
AN:
33228
American (AMR)
AF:
0.256
AC:
11312
AN:
44110
Ashkenazi Jewish (ASJ)
AF:
0.404
AC:
10324
AN:
25534
East Asian (EAS)
AF:
0.439
AC:
17318
AN:
39410
South Asian (SAS)
AF:
0.490
AC:
40967
AN:
83566
European-Finnish (FIN)
AF:
0.473
AC:
25034
AN:
52976
Middle Eastern (MID)
AF:
0.443
AC:
2509
AN:
5662
European-Non Finnish (NFE)
AF:
0.496
AC:
545512
AN:
1100410
Other (OTH)
AF:
0.456
AC:
27182
AN:
59574
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
16208
32416
48625
64833
81041
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15872
31744
47616
63488
79360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.364
AC:
55336
AN:
152072
Hom.:
12129
Cov.:
32
AF XY:
0.365
AC XY:
27153
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.109
AC:
4543
AN:
41508
American (AMR)
AF:
0.316
AC:
4832
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.416
AC:
1444
AN:
3468
East Asian (EAS)
AF:
0.450
AC:
2325
AN:
5170
South Asian (SAS)
AF:
0.495
AC:
2388
AN:
4820
European-Finnish (FIN)
AF:
0.472
AC:
4983
AN:
10556
Middle Eastern (MID)
AF:
0.446
AC:
131
AN:
294
European-Non Finnish (NFE)
AF:
0.491
AC:
33375
AN:
67952
Other (OTH)
AF:
0.379
AC:
799
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1609
3217
4826
6434
8043
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
536
1072
1608
2144
2680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.440
Hom.:
7812
Bravo
AF:
0.339
Asia WGS
AF:
0.476
AC:
1657
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Duane retraction syndrome 2 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
4.1
DANN
Benign
0.38
PhyloP100
0.035
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12613075; hg19: chr2-175677022; API